Skip to main content
. 2020 Oct 23;6(4):241. doi: 10.3390/jof6040241

Table 2.

Approved antifungals for clinical usage.

Antifungal Class Fungal Targets Mechanism of Action Limitation References
Azoles Aspergillus, Candida, Cryptococcus Interference with ergosterol biosynthesis via 14α-demethylase inhibition Fungistatic [4,5]
Polyenes Aspergillus, Candida, Cryptococcus, Histoplasma, Blastomyces Ergosterol extraction from plasma membrane Toxicity [4]
Echinocandins Aspergillus, Candida β-1,3-glucan synthase inhibition Poor oral bioavailability [7]